Prevention of writhing and other effects of narcotics and narcotic antagonists in mice.
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use; D008297:Male; D008614:Meperidine / Q000627:therapeutic use; D051379:Mice; D009020:Morphine / Q000627:therapeutic use; D009269:Nalorphine / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*; D010423:Pentazocine / Q000627:therapeutic use; D011804:Quinolines; D012640:Seizures / Q000139:chemically induced / Q000517:prevention & control*
D000700:Analgesics; D001952:Bridged-Ring Compounds; D009292:Narcotic Antagonists; D009294:Narcotics; D011804:Quinolines; D009020:Morphine; D008614:Meperidine; D010423:Pentazocine; D009269:Nalorphine